S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues

FASEB Journal

Volumn 22, Issue 1, 2008, Pages 307-315

  Allende, Maria L ^a   Zhou, Dapeng ^b   Kalkofen, Danielle N ^a   Benhamed, Sonia ^a   Tuymetova, Galina ^a   Borowski, Christine ^c   Bendelac, Albert ^c   Proia, Richard L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Conditional knockout mice; G protein coupled receptors; Lipid signaling; Lymphocyte trafficking

Indexed keywords

FINGOLIMOD; RECEPTOR; SIP1 RECEPTOR; UNCLASSIFIED DRUG; PRIMER DNA; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; LYMPHOCYTE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; TISSUE DISTRIBUTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENETICS; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; FLOW CYTOMETRY; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION;

EID: 38049160707     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-9087com     Document Type: Article

References (72)

1. Goetzl, E. J., and Rosen, H. (2004) Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J. Clin. Invest. 114, 1531-1537
2. Cyster, J. G. (2005) Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23, 127-159
3. Ley, K., and Morris, M. (2005) Signals for lymphocyte egress. Nat. Immunol. 6, 1215-1216
4. Rosen, H., and Goetzl, E. J. (2005) Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5, 560-570
5. Massberg, S., and von Andrian, U. H. (2006) Fingolimod and sphingosine-1-phosphate-modifiers of lymphocyte migration. N. Engl. J. Med. 355, 1088-1091
6. Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., and Cyster, J. G. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355-360
7. Lo, C. G., Xu, Y., Proia, R. L., and Cyster, J. G. (2005) Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201, 291-301
8. Cinamon, G., Matloubian, M., Lesneski, M. J., Xu, Y., Low, C., Lu, T., Proia, R. L., and Cyster, J. G. (2004) Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5, 713-720
9. Kabashima, K., Haynes, N. M., Xu, Y., Nutt, S. L., Allende, M. L., Proia, R. L., and Cyster, J. G. (2006) Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203, 2683-2690
10. Allende, M. L., Dreier, J. L., Mandala, S., and Proia, R. L. (2004) Expression of the sphingosine-1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279, 15396-15401
11. Allende, M. L., Yamashita, T., and Proia, R. L. (2003) G-protein coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102, 3665-3667
12. Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C. X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S. S., Lee, M. J., Liu, C. H., Hla, T., Spiegel, S., and Proia, R. L. (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951-961
13. Hla, T. (2004) Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell. Dev. Biol. 15, 513-520
14. Spiegel, S., and Milstien, S. (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell. Biol. 4, 397-407
15. Yatomi, Y., Ozaki, Y., Ohmori, T., and Igarashi, Y. (2001) Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid. Mediat. 64, 107-122
16. Olivera, A., Kohama, T., Edsall, L., Nava, V., Cuvillier, O., Poulton, S., and Spiegel, S. (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell Biol. 147, 545-558
17. Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y. W., Huang, Y., Cyster, J. G., and Coughlin, S. R. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316, 295-298
18. Hanel, P., Andreani, P., and Graler, M. H. (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 21, 1202-1209
19. Yatomi, Y., Yamamura, S., Ruan, F., and Igarashi, Y. (1997) Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J. Biol. Chem. 272, 5291-5297
20. Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., and Proia, R. L. (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279, 52487-52492
21. Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., and Cyster, J. G. (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735-1739
22. Chiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M., and Hoshino, Y. (1998) FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160, 5037-5044
23. Brinkmann, V., Pinschewer, D., Chiba, K., and Feng, L. (2000) FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol. Sci. 21, 49-52
24. Yagi, H., Kamba, R., Chiba, K., Soga, H., Yaguchi, K., Nakamura, M., and Itoh, T. (2000) Immunosuppressant FTY720 inhibits thymocyte emigration. Eur. J. Immunol. 30, 1435-1444
25. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C. A., Zollinger, M., and Lynch, K. R. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457
26. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G. J., Card, D., Keohane, C., Rosenbach, M., Hale, J., Lynch, C. L., Rupprecht, K., Parsons, W., and Rosen, H. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349
27. Forrest, M., Sun, S. Y., Hajdu, R., Bergstrom, J., Card, D., Doherty, G., Hale, J., Keohane, C., Meyers, C., Milligan, J., Mills, S., Nomura, N., Rosen, H., Rosenbach, M., Shei, G. J., Singer, I. I., Tian, M., West, S., White, V., Xie, J., Proia, R. L., and Mandala, S. (2004) Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J. Pharmacol. Exp. Ther. 309, 758-768
28. Hale, J. J., Neway, W., Mills, S. G., Hajdu, R., Ann Keohane, C., Rosenbach, M., Milligan, J., Shei, G. J., Chrebet, G., Bergstrom, J., Card, D., Koo, G. C., Koprak, S. L., Jackson, J. J., Rosen, H., and Mandala, S. (2004) Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorg. Med. Chem. Lett. 14, 3351-3355
29. Alfonso, C., McHeyzer-Williams, M. G., and Rosen, H. (2006) CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors. Eur. J. Immunol. 36, 149-159
30. Billich, A., Bornancin, F., Devay, P., Mechtcheriakova, D., Urtz, N., and Baumruker, T. (2003) Phosphorylation of the imunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278, 47408-47415
31. Paugh, S.W., Payne, S. G., Barbour, S. E., Milstien, S., and Spiegel, S. (2003) The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554, 189-193
32. Sanchez, T., Estrada-Hernandez, T., Paik, J. H., Wu, M. T., Venkataraman, K., Brinkmann, V., Claffey, K., and Hla, T. (2003) Phosphorylation and action of the immunomodulator FTY720 inhibits VEGF-induced vascular permeability. J. Biol. Chem. 278, 47281-47286
33. Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O'neill, S., L., Morris, M. A., Setiady, Y., Zhu, R., Zigler, M. A., Burcin, T. L., Ley, K., Tung, K. S., Engelhard, V. H., Macdonald, T. L., and Lynch, K. R. (2005) Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280, 36865-38672
34. Fu, S., Yopp, A. C., Mao, X., Chen, D., Zhang, N., Chen, D., Mao, M., Ding, Y., and Bromberg, J. S. (2004) CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am. J. Transplant. 4, 65-78
35. Sawicka, E., Dubois, G., Jarai, G., Edwards, M., Thomas, M., Nicholls, A., Albert, R., Newson, C., Brinkmann, V., and Walker, C. (2005) The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J. Immunol. 175, 7973-7980
36. Bendelac, A., Rivera, M. N., Park, S. H., and Roark, J. H. (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15, 535-562
37. Kronenberg, M. (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877-900
38. Zhou, D., Mattner, J., Cantu, C., 3rd, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y. P., Yamashita, T., Teneberg, S., Wang, D., Proia, R. L., Levery, S. B., Savage, P. B., Teyton, L., and Bendelac, A. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789
39. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H., and Taniguchi, M. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629
40. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P., and Kronenberg, M. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521-1528
41. Kinjo, Y., Wu, D., Kim, G., Xing, G. W., Poles, M. A., Ho, D. D., Tsuji, M., Kawahara, K., Wong, C. H., and Kronenberg, M. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525
42. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C., 3rd, Zhou, D., Saint-Mezard, P., Wang, V., Gao, Y., Yin, N., Hoebe, K., Schneewind, O., Walker, D., Beutler, B., Teyton, L., Savage, P. B., and Bendelac, A. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529
43. Benlagha, K., Kyin, T., Beavis, A., Teyton, L., and Bendelac, A. (2002) A thymic precursor to the NK T cell lineage. Science 296, 553-555
44. Berzins, S. P., McNab, F. W., Jones, C. M., Smyth, M. J., and Godfrey, D. I. (2006) Long-term retention of mature NK1.1+ NKT cells in the thymus. J. Immunol. 176, 4059-4065
45. Hammond, K. J., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. R., Scollay, R., Baxter, A. G., and Godfrey, D. I. (1999) NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29, 3768-3781
46. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000) NKT cells: facts, functions and fallacies. Immunol. Today 21, 573-583
47. Godfrey, D. I., and Kronenberg, M. (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388
48. Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995) Inducible gene targeting in mice. Science 269, 1427-1429
49. Liu, Y., Goff, R. D., Zhou, D., Mattner, J., Sullivan, B. A., Khurana, A., Cantu, C., 3rd, Ravkov, E. V., Ibegbu, C. C., Altman, J. D., Teyton, L., Bendelac, A., and Savage, P. B. (2006) A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312, 34-39
50. Pellicci, D. G., Hammond, K. J., Uldrich, A. P., Baxter, A. G., Smyth, M. J., and Godfrey, D. I. (2002) A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195, 835-844
51. Hennet, T., Hagen, F. K., Tabak, L. A., and Marth, J. D. (1995) T-cell-specific deletion of a polypeptide N-acetylgalactosaminyltransferase gene by site-directed recombination. Proc. Natl. Acad. Sci. U. S. A. 92, 12070-12074
52. Gapin, L., Matsuda, J. L., Surh, C. D., and Kronenberg, M. (2001) NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2, 971-978
53. Egawa, T., Eberl, G., Taniuchi, I., Benlagha, K., Geissmann, F., Hennighausen, L., Bendelac, A., and Littman, D. R. (2005) Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22, 705-716
54. Wei, D. G., Lee, H., Park, S. H., Beaudoin, L., Teyton, L., Lehuen, A., and Bendelac, A. (2005) Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202, 239-248
55. Nagahara, Y., Enosawa, S., Ikekita, M., Suzuki, S., and Shinomiya, T. (2000) Evidence that FTY720 induces T cell apoptosis in vivo. Immunopharmacology 48, 75-85
56. Sugito, K., Koshinaga, T., Inoue, M., Ikeda, T., Hagiwara, N., Kusafuka, T., and Fukuzawa, M. (2006) Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues. Transplant Proc. 38, 3058-3060
57. Hashimoto, D., Asakura, S., Matsuoka, K., Sakoda, Y., Koyama, M., Aoyama, K., Tanimoto, M., and Teshima, T. (2007) FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease. Eur. J. Immunol. 37, 271-281
58. Kim, C. H., Johnston, B., and Butcher, E. C. (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100, 11-16
59. Laloux, V., Beaudoin, L., Ronet, C., and Lehuen, A. (2002) Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes. J. Immunol. 168, 3251-3258
60. Mempel, M., Ronet, C., Suarez, F., Gilleron, M., Puzo, G., Van Kaer, L., Lehuen, A., Kourilsky, P., and Gachelin, G. (2002) Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J. Immunol. 168, 365-371
61. Thomas, S. Y., Hou, R., Boyson, J. E., Means, T. K., Hess, C., Olson, D. P., Strominger, J. L., Brenner, M. B., Gumperz, J. E., Wilson, S. B., and Luster, A. D. (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171, 2571-2580
62. Arbones, M. L., Ord, D. C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, D. J., and Tedder, T. F. (1994) Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1, 247-260
63. Tedder, T. F., Steeber, D. A., and Pizcueta, P. (1995) L-selectindeficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med. 181, 2259-2264
64. Xu, J., Grewal, I. S., Geba, G. P., and Flavell, R. A. (1996) Impaired primary T cell responses in L-selectin-deficient mice. J. Exp. Med. 183, 589-598
65. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., and Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33
66. Lee, P. T., Benlagha, K., Teyton, L., and Bendelac, A. (2002) Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195, 637-641
67. Eger, K. A., Sundrud, M. S., Motsinger, A. A., Tseng, M., Kaer, L. V., and Unutmaz, D. (2006) Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions. PLoS ONE 1, e50
68. Franki, A. S., Van Beneden, K., Dewint, P., Hammond, K. J., Lambrecht, S., Leclercq, G., Kronenberg, M., Deforce, D., and Elewaut, D. (2006) A unique lymphotoxin α beta-dependent pathway regulates thymic emigration of Vα 14 invariant natural killer T cells. Proc. Natl. Acad. Sci. U. S. A. 103, 9160-9165
69. Graler, M. H., and Goetzl, E. J. (2004) The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18, 551-553
70. Gonzalez-Cabrera, P. J., Hla, T., and Rosen, H. (2007) Mapping pathways downstream of S1P1 by differential chemical perturbation and proteomics. J. Biol. Chem. 282, 7254-7264
71. Oo, M. L., Thangada, S., Wu, M. T., Liu, C. H., Macdonald, T. L., Lynch, K. R., Lin, C. Y., and Hla, T. (2007) Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J. Biol. Chem. 282, 9082-9089
72. Wei, S. H., Rosen, H., Matheu, M. P., Sanna, M. G., Wang, S. K., Jo, E., Wong, C. H., Parker, I., and Cahalan, M. D. (2005) Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6, 1228-1235